Susquehanna Fundamental Investments, LLC Royalty Pharma PLC Transaction History

Susquehanna Fundamental Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $7.87 Million - $8.81 Million	197,265 New	197,265 $7.93 Million
Q2 2021 Aug 11, 2021	SELL	$39.85 - $46.63 $662,785 - $775,550	-16,632 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$42.34 - $52.82 $2.24 Million - $2.8 Million	-53,008 Reduced 76.12%	16,632 $725,000
Q4 2020 Feb 16, 2021	SELL	$36.12 - $50.05 $1.7 Million - $2.35 Million	-46,960 Reduced 40.27%	69,640 $3.49 Million
Q3 2020 Nov 16, 2020	BUY	$38.56 - $48.36 $3.13 Million - $3.92 Million	81,100 Added 228.45%	116,600 $4.91 Million
Q2 2020 Aug 14, 2020	BUY	$44.5 - $52.11 $1.58 Million - $1.85 Million	35,500 New	35,500 $1.72 Million

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.